哥伦比亚 INVIMA 医疗器械认证全解析 - Wiselink Group-A More Controllable, Stable, and Future-Oriented Material Direction

Home > News Center > Full Analysis of Colombia INVIMA Medical Device Certification

Full Analysis of Colombia INVIMA Medical Device Certification

Time：2026-07-07 13:59:41

With the rapid development of the medical and health industry in Latin America, Colombia has become a core destination for medical device enterprises to expand into the South American market, backed by its stable market environment and growing medical demand. The only legal access to the Colombian market is to complete the INVIMA medical device registration certification. This article comprehensively sorts out the core rules of Colombia INVIMA certification to help enterprises quickly grasp key access points.

一、Regulatory Authority and Core Regulatory Framework

Colombia's official regulatory body for medical devices is the Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA, National Institute for Drug and Food Surveillance), which is affiliated with the Colombian Ministry of Health. It takes charge of the full-chain supervision covering regulation formulation and implementation, medical device market access management, post-marketing supervision and inspection.

The core regulations for medical device supervision in Colombia currently include:

General regulatory decree: DECRETO 582 DE 2017
Special decree for medical devices (MD): DECRETO NÚMERO 4725 DE 2005
Special decree for in vitro diagnostic products (IVD): DECRETO NÚMERO 3770 DE 2004

二、Product Risk Classification Rules

INVIMA implements tiered management for medical devices and IVD products. The risk level directly determines the registration path, review intensity, processing cycle and fees.

1. General Medical Devices (MD)

Pursuant to Decree No. 4725/2005, medical devices are classified into 4 tiers from low to high risk:

Class Ⅰ: Low risk
Class IIa: Medium-low risk
Class IIb: Medium-high risk
Class Ⅲ: High risk

2. In Vitro Diagnostic Products (IVD)

IVD products follow an independent classification system with 3 risk levels:

Class I (Low risk): Representative products include blood glucose test strips and urine analysis test strips
Class II (Medium risk): Representative products include microbial culture media, partial biochemical analyzers and blood typing reagents
Class III (High risk): Representative products include gene diagnostic reagents, tumor marker detection reagents and high-end molecular diagnostic equipment

三、Three Essential Requirements for INVIMA Registration

To apply for Colombia INVIMA certification, enterprises shall meet three basic access requirements first:

Quality Management System CertificationThe manufacturer shall provide compliance documents of the quality management system. Among them, the ISO 13485 certificate is the most widely recognized and commonly adopted compliance document accepted by INVIMA.

Local Registration HolderA registration holder based in Colombia must be appointed as the local legal representative, responsible for liaising with INVIMA, delivering regulatory communications and cooperating with post-marketing supervision work.

Compliance Documents and Language RequirementsA Free Sale Certificate (FSC) issued by the competent authority of the country of origin, or by Australia, the European Union, Canada, Japan or the United States shall be provided. The FSC must be apostilled under the Hague Convention and translated into Spanish. Application documents shall be submitted in Spanish in principle; for some technical documents, English originals with Spanish summaries are acceptable.

四、Registration Process, Cycle and Official Fees

1. Standard Registration Process

INVIMA registration follows a standardized application pathway, with core procedures as follows:

Confirm product classification: Judge the product risk level in accordance with regulatory standards, and confirm the applicable application channel
Select registration path: Match the review pathway corresponding to the risk level
Prepare application materials: Divided into three categories — quality system documents (ISO 13485), notarized documents (Power of Attorney (POA), Free Sale Certificate (FSC)), and technical & product registration materials
Compile and submit the formal registration application
Official review by separate pathways:
- Path A: Class I / Class IIa products enter the fast-track review channel for low-risk products
- Path B: Class IIb / Class III products enter the dedicated review channel for high-risk products
Obtain the registration certificate upon approval

2. Official Review Cycle
The review duration is directly correlated with the product risk level:
Class I / Class IIa products: Regular review cycle of 1–2 months
Class IIb / Class III products: Regular review cycle of 4–6 months
The actual cycle may be affected by factors such as product technical complexity, quality of application materials and official review schedule.

3. Official Registration Fee Standards
Class I ~ Class IIa: USD 1,298
Class IIb ~ Class III: USD 1,147

4. Certificate Validity and Renewal
The INVIMA medical device registration certificate is valid for 10 years. Enterprises shall submit a renewal application before the certificate expires. In practice, it is recommended to start material preparation and application work at least 3 months in advance to avoid certificate expiration that disrupts market sales.

五、Conclusion

The Colombia INVIMA certification system features a clear framework: low-risk products enjoy high access efficiency, while high-risk products set higher requirements for the completeness of technical documents. Enterprises that complete product classification judgment and material preparation in advance can effectively improve the registration pass rate and shorten the access cycle. For further inquiries, please contact Wiselink!

As the largest medical device market with the most sophisticated regulatory system in Latin America, Brazil serves as a core foothold for Chinese medical device enterprises to deploy in the South American market. On the occasion of Wiselink's 6th Anniversary Celebration, we launch a limited-time offer: from June 18 to July 18, all risk levels of medical device products for the Brazilian market are entitled to a 20% discount on consulting service fees. We welcome both new and existing customers to consult us!

Previous：High-Risk Aesthetic Medical Device Market Access in Southeast Asia (Part 2): A Guide to Accelerating Compliance Registration in Malaysia and Vietnam Next：Comprehensive Guide to Medical Device Registration in Japan and Common Pitfalls to Avoid

Fill Form

Whether you need more information or wish to cooperate with us, we will guide you through every step of the regulatory process. Subscribe to our newsletter for the latest global regulatory updates.